Stage IV Triple-Negative Breast Cancer: Deltra's Patient Story

What happened, in summary

Deltra James was diagnosed at 33 with de novo Stage IV triple-negative metastatic breast cancer. Her advocacy has focused not only on living with advanced cancer, but also on quality-of-life issues that many patients are embarrassed to raise. In this 2024 conversation with Melissa Berry, Deltra helped bring sexual health into the open. Treatment and long-term medication can affect libido, vaginal dryness, pain with intercourse, fatigue, body image, and emotional closeness, and those changes can feel isolating when patients are expected to simply be grateful to be alive. Deltra's message is that intimacy after cancer can be rebuilt with honesty, medical support, and self-compassion. She encourages people to talk with partners, ask oncology teams about sexual side effects, and seek practical tools rather than silently accept pain or shame. Her perspective is shaped by metastatic disease, motherhood, advocacy, and the ongoing work of living in a body changed by cancer. As of December 2024, Deltra was living with metastatic breast cancer and using her voice to make intimacy, confidence, and sexual health part of survivorship and metastatic-care conversations, not an afterthought. This framing matters because sexual health, pain, and desire are often left out of oncology visits even when they strongly affect day-to-day life.